Postado por poscardio em 25/set/2013 - Sem Comentários
Professor Convidado: Prof. Dr. Franz Porzsolt,f.porzsolt@gmx.de
Health Care Research at the Hospital for General and Visceral Surgery, University Hospital Ulm, Albert-Einstein-Allee 23, 89070 Ulm / Germany.
Institute of Clinical Economics, affiliated to the University of Applied Sciences Neu-Ulm, HochschulschlossVöhlin, Schlossallee 25, 89257 Illertissen.
Institute of Clinical Economics [ICE] e.V., registered association, HochschulschlossVöhlin, Schlossallee 25, 89257 Illertissen
Organização: Prof. Dr. Tania Thomaz, tania_thomaz@id.uff.br
Departamento de Fisiologia e Farmacologia
Pós-graduação em Ciências Cardiovasculares
Universidade Federal Fluminense
Data: 02a 10 de outubro de 2013
Rio de Janeiro
Horário: 11 – 13 horas
Local: Sala Aluísio Brasil, 2º andar do prédio anexo do Hospital Universitário Antônio Pedro – UFF, Faculdade de Medicina, Rua Marquês do Paraná, 303. Niterói-RJ
Inscrições: até 27 de setembro de 2013 (VAGAS LIMITADAS – INSCRIÇÕES GRATUITAS) pelo site http://promo.medportal.com.br/ebm
|
Present understanding of Evidence-based Medicine Outline of the EbM-course in seven lectures |
||
| 26/09 | Introdução – Tania Thomaz | |
| 1 | 02/10 |
Even evidence-based decisions are subjective decisions. The six steps from the clinical problem to the solution. |
| 2 | 03/10 |
Errors and types of health care services (prevention). Random and systematic errors (bias), frequent forms of bias. Screening, diagnosis and treatment in primary, secondary, and tertiary prevention |
| 3 | 04/10 |
Methods for transforming information to knowledge. Randomized Controlled Trial, Pragmatic Controlled Trial, Registry. History of clinical trials, the problem of preference, randomization, blinding, concealment, stratification, the power of information, surrogate and patient related endpoints (DFS, PFS, OS), which study design for which study question, external and internal validity |
| 4 | 07/10 |
From the study question to the result of the study. Question, goal, value, methods, conduct, homogeneity of trial, bias, inclusion & exclusion criteria, patient characteristics, baseline risks, follow up, performance, attrition, detection, intent-to-treat, per protocol analysis |
| 5 | 08/10 |
Evaluation and interpretation of results. Description or testing a hypothesis (superiority/inferiority), statistical tests, margins, Absolute Risk Reduction (ARR), Relative Risk Reduction (RRR), Number Needed to Treat (NNT)/Harm (NNH), Incremental Cost Effectiveness Ratio (ICER) & Cost Of Additional Treatment Success (COATS), significance & relevance of results, interpretation and consequences, publication bias.
|
| 6 | 09/10 |
Meta-Analyses.
Based on individual data, individual publications, reviews. Protocol. Description of search strategy. Grey literature. Validity of included trials. Presentation of results, Funnel plot. Examples
|
| 7 | 10/10 |
Instruments for assessing the validity of scientific information. Levels of evidence, observational studies and molecular biology (STROBE-ME), Randomized Controlled Trials (CONSORT), Randomized Controlled Trials and Pragmatic Controlled Trials (USP), Systematic review/Meta-Analysis (PRISMA) |
| 17/10 | Avaliação – Tania Thomaz | |
Informações de contato da Coordenação:
Endereço:
Rua Desembargador Athayde Parreiras, 100
Bairro Fátima, Niterói - RJ, CEP 24070-090
5º andar, Sala 6
Horários de Atendimento:
E-mail para Contato:
ppgccv.cmm@id.uff.br
Copyright 2025 - STI - Todos os direitos reservados
